Literature DB >> 11224836

Differing manifestations of respiratory syncytial virus-associated severe lower respiratory tract infections in human immunodeficiency virus type 1-infected and uninfected children.

S A Madhi1, M Venter, A Madhi, M K Petersen, K P Klugman.   

Abstract

BACKGROUND: Respiratory syncytial virus (RSV) causes increased morbidity and mortality in immunocompromised children. The outcome of RSV-associated lower respiratory tract infections (LRTI) in HIV-infected children, is less well described.
METHODS: Children from a prospective study evaluating the etiology of

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11224836     DOI： 10.1097/00006454-200102000-00010

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  11 in total

1.  Identification of deletion mutant respiratory syncytial virus strains lacking most of the G protein in immunocompromised children with pneumonia in South Africa.

Authors:  Marietjie Venter; Stephanie van Niekerk; Andronica Rakgantso; Nicola Bent
Journal:  J Virol       Date:  2011-06-15       Impact factor: 5.103

Review 2.  Respiratory viruses other than influenza virus: impact and therapeutic advances.

Authors:  W Garrett Nichols; Angela J Peck Campbell; Michael Boeckh
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

3.  Successive Respiratory Syncytial Virus Epidemics in Local Populations Arise from Multiple Variant Introductions, Providing Insights into Virus Persistence.

Authors:  Charles N Agoti; James R Otieno; Mwanajuma Ngama; Alexander G Mwihuri; Graham F Medley; Patricia A Cane; D James Nokes
Journal:  J Virol       Date:  2015-09-09       Impact factor: 5.103

4.  Contribution of common and recently described respiratory viruses to annual hospitalizations in children in South Africa.

Authors:  Marietjie Venter; Ria Lassaunière; Tina Louise Kresfelder; Yvette Westerberg; Adele Visser
Journal:  J Med Virol       Date:  2011-08       Impact factor: 2.327

5.  Case fatality rate and viral aetiologies of acute respiratory tract infections in HIV positive and negative people in Africa: The VARIAFRICA-HIV systematic review and meta-analysis.

Authors:  Sebastien Kenmoe; Jean Joel Bigna; Abdou Fatawou Modiyingi; Marie S Ndangang; Paul Alain Ngoupo; Fredy Brice N Simo; Serges Tchatchouang; Elvis Temfack; Richard Njouom
Journal:  J Clin Virol       Date:  2019-06-28       Impact factor: 3.168

6.  Factors associated with increased risk of progression to respiratory syncytial virus-associated pneumonia in young Kenyan children.

Authors:  Emelda A Okiro; Mwanajuma Ngama; Ann Bett; Patricia A Cane; Graham F Medley; D James Nokes
Journal:  Trop Med Int Health       Date:  2008-05-08       Impact factor: 2.622

7.  Respiratory Syncytial Virus Vaccine Approaches: a Current Overview.

Authors:  Carolyn M Clark; Antonieta Guerrero-Plata
Journal:  Curr Clin Microbiol Rep       Date:  2017-10-16

8.  Clinical epidemiology of bocavirus, rhinovirus, two polyomaviruses and four coronaviruses in HIV-infected and HIV-uninfected South African children.

Authors:  Marta C Nunes; Zachary Kuschner; Zelda Rabede; Richard Madimabe; Nadia Van Niekerk; Jackie Moloi; Locadiah Kuwanda; John W Rossen; Keith P Klugman; Peter V Adrian; Shabir A Madhi
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

9.  Human metapneumovirus-associated lower respiratory tract infections among hospitalized human immunodeficiency virus type 1 (HIV-1)-infected and HIV-1-uninfected African infants.

Authors:  Shabir A Madhi; Herbert Ludewick; Yacine Abed; Keith P Klugman; Guy Boivin
Journal:  Clin Infect Dis       Date:  2003-11-19       Impact factor: 9.079

10.  Respiratory viruses in young South African children with acute lower respiratory infections and interactions with HIV.

Authors:  Alicia A Annamalay; Salome Abbott; Chisha Sikazwe; Siew-Kim Khoo; Joelene Bizzintino; Guicheng Zhang; Ingrid Laing; Glenys R Chidlow; David W Smith; James Gern; Jack Goldblatt; Deborah Lehmann; Robin J Green; Peter N Le Souëf
Journal:  J Clin Virol       Date:  2016-06-04       Impact factor: 3.168
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.